BENGALURU: In an innovative partnership to manage diabetes, Sweden-based Brighter has selected Ericsson’s Device Connection Platform (DCP) as its global connectivity management platform for m-health solutions.
Brighter will standardize its solutions using DCP and leverage the platform for lifecycle management, control and distribution of the next generation Brighter One, a connected device for diabetes treatment that combines blood sugar measurement and insulin injection capabilities.
Explaining the technology, company authorities said that through DCP, global operators will be able to connect their subscribers to The Benefit Loop, which creates the potential for new and innovative service offerings. Brighter aims to secure contracts with operators that offer connectivity management services through DCP.
DCP is a cloud-based Internet of Things (IoT)/machine-to-machine (M2M) platform that handles connectivity management, subscription management and OSS/BSS, enabling automation of business processes between operators and enterprises.
Speaking on the alliance, Anders Olin, VP of Product Area Network Functions, Business Unit Cloud & IP, Ericsson, said, “IoT is a key competence area for Ericsson and we see m-health as a sector with strong market potential. In today’s competitive ICT industry, operators can benefit from providing e-health services alongside traditional voice and data offerings. This collaboration combines the DCP with Brighter’s connected products, which can create new growth opportunities for global operators, as well as having a positive impact on patient health.”
Truls Sjöstedt, CEO of Brighter, stated, “Our cooperation with Ericsson gives us access both to the industry-leading DCP platform and some of the world’s largest operators. This is a win-win agreement under which all three parties can explore new business opportunities in the exciting and fast-growing m-health market.”
Connected solutions such as next generation Brighter One can be integrated into Brighter’s platform The Benefit Loop, in which patient data is continuously combined with additional relevant data to improve treatment and quality of life.
According to the World Health Organization, in 2014, nine percent of adults worldwide aged 18 years or older had diabetes. In 2012, diabetes was the direct cause of 1.5 million deaths, and the disease is projected to become the seventh-leading cause of death by 2030.